This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
Don’t drop the ball on HIV/Aids, says scientist
KZN’s top women researcher believes a game changer is around the corner. It needs political will and no geopolitical head ...
US aid freeze puts HIV-positive orphans in Kenya at risk as medical supplies dwindle
Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and ...
unaids1d
Three Years On: From crisis to prospective recovery
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) contributed US$15.6 million to the HIV response in Ukraine during 2023 and 2024. This includes $11 million for antiretroviral therapy and ...
Science Daily2d
New therapy may effectively control HIV in Uganda
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
BMJ2d
Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas
According to the definitions of the Life Cycle Initiative,13 the foreground system consists ... to the previously published LCA results for the TMC114FD1HTX1002 phase 1 HIV trial, we see some more ...
technologynetworks2d
Natural Resistance to New HIV Therapy Lencavir Uncommon in Ugandan Patients
New research has found little natural resistance to a new HIV therapy, adding to evidence that it may be a powerful tool in ...
Armed robbery in Revesby2d
Promising HIV Therapy Shows Success in Uganda
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called ...
News Medical2d
New HIV therapy lenacapavir shows high efficacy in Ugandan population
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
unaids3d
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them
On 20 January 2025 the United States announced a 90-day freeze on US foreign aid which has had a devastating impact on people living with and affected by HIV, on the people and organizations ...